Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Celvivo Aps is managing 1 pending office action in the Chemistry & Materials technology area. This action is assigned to 1 distinct examiner within 1 distinct art unit. The busiest examiner is KWAK, DEAN P, who is responsible for 1 pending office action.
The current prosecution profile for this company is concentrated, with only 1 pending office action across the entire portfolio. Because this 1 action is handled by 1 distinct examiner, the company's immediate patenting outcomes are tied to the specific review process of that individual. This lack of volume and diversity in examiners suggests a focused patent strategy where each office action carries weight for the portfolio's development. Practitioners must carefully tailor their responses to the preferences of KWAK, DEAN P, as there are no other active files to provide alternative prosecution paths. The presence of 1 distinct art unit confirms that the current activity is limited to a specific technical domain, requiring a targeted approach to overcome any rejections and secure allowance for the pending claims. This focused engagement allows for a deep dive into the specific prior art cited by the 1 examiner involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KWAK, DEAN P | 1 | 58.8% | +37.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260429 | IMAGE ANALYSIS AND NON-INVASIVE DATA COLLECTION FROM CELL CULTURE DEVICES | KWAK, DEAN P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260429 | IMAGE ANALYSIS AND NON-INVASIVE DATA COLLECTION FROM CELL CULTURE DEVICES | KWAK, DEAN P | — |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18260429 | IMAGE ANALYSIS AND NON-INVASIVE DATA COLLECTION FROM CELL CULTURE DEVICES | KWAK, DEAN P | 1798 | §102§112Other | Final Rejection | — | Pending | Jul 05, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCelvivo Aps has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Dean P Kwak has the most, with 1 of Celvivo Aps's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
